{"id":"https://openalex.org/A5050656167","orcid":null,"observed_orcids":[],"display_name":"Napat Pabmeechai","raw_author_names":["Napat Pabmeechai"],"full_name":"Napat Pabmeechai","works_count":1,"cited_by_count":3,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5050656167","orcid":null,"observed_orcids":[]},"affiliations":[],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":1,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","count":1,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":1,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","value":4.2e-06,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":2.3e-06,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","score":0.657619833946228},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.5129808783531189},{"id":"188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","score":0.49232685565948486},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.4498696029186249},{"id":"147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","score":0.31856775283813477}],"counts_by_year":[{"year":2013,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":1}],"display_name_alternatives":["Napat Pabmeechai"],"block_key":"n pabmeechai","works_api_url":"https://api.openalex.org/works?filter=author.id:A5050656167","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5050656167","updated_date":"2026-11-21T13:19:37","created_date":"2016-06-24T00:00:00"}
